NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/04/2026
Back to search
Official data from USPTO
DAIICHI-SANKYO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
02/05/2026
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
12/07/2012
Registration date
03/17/2015
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2026
Last transaction
02/05/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Tokyo, JP
Examiner
ROACH, APRIL K
Current location
Historical data usage
Mark description
The mark consists of the stylized wording "DAIICHI SANKYO" below a partial circle displayed within a circular design.
Holders and representatives
Holders
DAIICHI SANKYO COMPANY, LIMITED
Representatives
Bassam N. Ibrahim BUCHANAN INGERSOLL & ROONEY, PC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical food preservatives; chemical plasticizers for use as high polymer stabilizers for plastics and paints; synthetic chemical polymer stabilizers for use as light stabilizers for plastics and coatings; chemical additives for use in the manufacture of foods; chemical antioxidants for use in the manufacture of drinkscakesflavoring agentsdairy products and fish paste products; chemical germination controllersgibberellins for grapesoranges and for domestic and agricultural use; diagnostic reagents for in vitro scientific use; diagnostic preparations for in vitro biological testsfor urine and blood testsfor blood glucose testsfor clotting testsall for scientific use; enzyme preparations for use in vitro scientific use; soil conditionerssoil improving agents and plant growth regulators for agricultural use; tetrodotoxins for scientific research use; adhesives not for stationery or household purposes; plant growth regulating preparations; fertilizers; higher fatty acid for use as food additive; chemical test paper; artificial sweeteners
Class 5
Full line of pharmaceutical preparations ; veterinary drugs for the treatment of distemper in dogsdistomatosis in dogscoccidium in chickens and dysentery in pigs; sanitary preparations for medical use and sanitary preparations for agricultural useherbicidesfungicidesinsecticidesbactericides and rodenticides; oiled paper for medical purposes; wafer for wrapping a dose of powdered medicineunit dose gelatin or starch based dissolvable thin film sold empty for pharmaceuticals; gauze for dressings; unit dose capsules sold empty for pharmaceuticals; eye patches for medical use; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical use; adhesive plasters for medical use; bandages for dressings; collodion for medical use; breast-nursing pads; dental impression material; dental cements; dental abrasives; dental mastics; lactose for pharmaceutical purposes; powdered milk for babies; dietetic beverages adapted for medical purposes; baby foods; edible plant fibersdietary fibers for use as non-nutritive additives for food products to aid digestion; ground flaxseed fibers used in dietary supplements
Class 42
Technical research in the fields of pharmaceutical productsmedicines and cosmetics; project studiesresearch relating to new productspharmacokineticsclinical trialsclinical studies of product effectivenesssafety and adverse reactionscontraindication in the fields of pharmaceutical productsmedicines and cosmetics; technical project studiesresearch relating to new productspharmacokineticsclinical trialsclinical studies of product effectivenesssafety and adverse reactionscontraindication in the fields of pharmaceutical productsmedicines and cosmetics; research on civil engineering; research and development for others in the fields of pharmaceutical productsmedicines and cosmetics; quality testing in the fields of pharmaceutical productsmedicines and cosmetics; quality evaluation in the fields of pharmaceutical productsmedicines and cosmetics; chemical analysis in the fields of pharmaceutical productsmedicines and cosmetics; chemistry services in the nature of chemical consultation in the fields of pharmaceutical productsmedicines and cosmetics; chemical research in the fields of pharmaceutical productsmedicines and cosmetics; cosmetic research; bacteriological research for pharmaceutical preparations and medicine; biological research for pharmaceutical preparations and medicine; product research and development in the fields of medical and pharmaceutical preparations and medicines; research and development relating to manufacturing processes in the fields of medical and pharmaceutical preparations and medicines; research and developmentconducting clinical trials for others
Class 44
Medical clinics; hospitals; health care; medical assistance; physical therapy; medical nursing; pharmaceutical advice; plastic surgery; telemedicine services; pharmacists' services to make up prescriptions; veterinary assistance; providing healthcare advisory services and information in the fields of pharmaceutical preparationspharmaceutical productsmedicinesmedical treatmentdiseases and administration of medicines; preparation and dispensing of medications; medical services; * and/or * providing information relating to healthcare
Publications
History of USPTO decisions and trademark events.
52 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
02/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/13/2026
ES71
TEAS SECTION 71 RECEIVED
09/10/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/17/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/28/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/17/2023
INPC
INVALIDATION PROCESSED
02/17/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/06/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/27/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/27/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
04/27/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/27/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
09/17/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/17/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/26/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/23/2015
FIMP
FINAL DISPOSITION PROCESSED
07/23/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2014
PUBO
PUBLISHED FOR OPPOSITION
12/30/2014
GPNX
NOTIFICATION PROCESSED BY IB
12/26/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/10/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/10/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/24/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/21/2014
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/22/2014
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/16/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/06/2014
GNFR
FINAL REFUSAL E-MAILED
06/06/2014
CNFR
FINAL REFUSAL WRITTEN
06/06/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/15/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2014
ALIE
ASSIGNED TO LIE
05/05/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/18/2014
RFNT
REFUSAL PROCESSED BY IB
01/06/2014
MAFR
APPLICATION FILING RECEIPT MAILED
12/17/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/16/2013
RFRR
REFUSAL PROCESSED BY MPU
12/16/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/14/2013
CNRT
NON-FINAL ACTION WRITTEN
12/13/2013
DOCK
ASSIGNED TO EXAMINER
12/11/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2013
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/09/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/06/2013
Continuous trademark protection
Get notified about every new filing that threatens DAIICHI-SANKYO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.